Table 3.

Blood glucose fluctuations of newly diagnosed T2DM patients.

	CSII N group	MDI3 N group	MDI4 N group
24 h MBG (mmol/L)
Before therapy	11.55 ± 2.63	12.51 ± 2.73	12.20 ± 2.74
After therapy	7.70 ± 1.79∗∗	7.55 ± 1.13∗∗	7.44 ± 1.40∗∗
MAGE
Before therapy	7.11 ± 2.87	6.87 ± 2.01	6.31 ± 3.62
After therapy	4.51 ± 1.92∗	5.05 ± 1.97∗	4.94 ± 2.21∗
The time spent (>10 mmol/L) (%)
Before therapy	62 ± 31	67 ± 29	66 ± 31
After therapy	14 ± 17∗∗	14 ± 13∗∗	12 ± 14∗∗
The time spent in <3.9 mmol/L (%)
Before therapy	2 ± 4	1.8 ± 5	2.6 ± 6
After therapy	0.32 ± 0.8∗∗	0.4 ± 0.8∗∗	0.7 ± 0.3∗∗
The time spent in normal glycaemia (%)
Before therapy	38 ± 31	33 ± 29	38 ± 36
After therapy	85 ± 16∗∗	83 ± 13∗∗	84 ± 15∗∗
The AUC (>10 mmol/L) (mmol/L per day)
Before therapy	2.55 ± 1.99	2.84 ± 2.29	2.81 ± 2.02
After therapy	0.29 ± 0.57∗∗	0.27 ± 0.37∗∗	0.27 ± 0.35∗∗
The AUC for <3.9 mmol/L (mmol/L per day)
Before therapy	0.02 ± 0.08	0.01 ± 0.05	0.02 ± 0.09
After therapy	0.00 ± 0.00∗∗	0.00 ± 0.02∗∗	0.00 ± 0.03∗∗

Data are mean ± (SD). ^∗ P < 0.05, ^∗∗ P < 0.01 versus the same item before therapy.